Cost of covering antiobesity drugs could be billions to Medicare despite, a new analysis finds
March 15, 2023
If newer brand-name antiobesity medications were covered by Medicare, they could cost the program between $13.6 to $26.8 billion even with only 10% of people with obesity using them, according to a new analysis published in the New England Journal of Medicine by Vanderbilt University Medical Center researchers in the Department of Health Policy.
Researchers recommend ways to measure ‘spillover effects’ on families, caregivers
August 24, 2022
Imagine the unthinkable: A child diagnosed with cancer who suddenly needs extensive treatment and care for a lengthy period. Researchers have long studied the economic value of that care (e.g., outcomes relative to cost) but measuring the impact of patient illness on parents or caregivers has been underestimated and inconsistently incorporated into economic evaluations.